BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 34607064)

  • 1. Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
    Reon BJ; Anaya J; Zhang Y; Mandell J; Purow B; Abounader R; Dutta A
    PLoS Med; 2016 Dec; 13(12):e1002192. PubMed ID: 27923049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
    Han Z; Jia J; Lv Y; Wang R; Cao K
    Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma.
    Niu H; Cao H; Liu X; Chen Y; Cheng Z; Long J; Li F; Sun C; Zuo P
    Am J Clin Oncol; 2024 Jun; 47(6):259-270. PubMed ID: 38318849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of histone acetylation-related genes in glioblastoma and lower-grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis.
    Qin J; Fu J; Chen X
    J Gene Med; 2024 Mar; 26(3):e3678. PubMed ID: 38500293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15 overexpression promotes cell proliferation and predicts poor prognosis in cerebral lower-grade gliomas correlated with hypoxia and glycolysis signature.
    Wang Y; Chen J; Chen C; Peng H; Lin X; Zhao Q; Chen S; Wang X
    Life Sci; 2022 Aug; 302():120645. PubMed ID: 35588865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients.
    Guo X; Piao H; Xue Y; Liu Y; Zhao H
    J Int Med Res; 2020 Sep; 48(9):300060520954764. PubMed ID: 32960116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline BRCA2 pathogenic variants in pediatric ganglioglioma: Case report and review of the literature.
    Gupta A; Lechpammer M; Brossier NM
    Childs Nerv Syst; 2024 May; 40(5):1609-1612. PubMed ID: 38168858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and expressions of breast cancer 1/2 in lung cancer.
    Yan B; Xie B; Huang M; Guo J; Sun J; Chen J; Tao Y; Xiao D
    Thorac Cancer; 2023 Jun; 14(18):1753-1763. PubMed ID: 37160413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Hallmark Pathway-Related Gene Signature Associated with Immune Response for Lower Grade Gliomas.
    Lai G; Zhong X; Liu H; Deng J; Li K; Xie B
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development.
    Chen Z; Wang X; Yan Z; Zhang M
    Cancer Med; 2022 Jul; 11(13):2711-2726. PubMed ID: 35285582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
    Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
    Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic Reprogramming as a Driver of Malignant Glioma.
    Phillips RE; Soshnev AA; Allis CD
    Cancer Cell; 2020 Nov; 38(5):647-660. PubMed ID: 32916125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostication Potential of BRCA Genes Expression in Gliomas: A Genetic Survival Analysis Study.
    Meimand SE; Pour-Rashidi A; Shahrbabak MM; Mohammadi E; Meimand FE; Rezaei N
    World Neurosurg; 2022 Jan; 157():e123-e128. PubMed ID: 34607064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.